OBD Oxford BioDynamics Plc

0.0015USD0.1150 GBp · LSE+4.55%Mkt Cap: 20.35M USDP/E: —

Oxford BioDynamics Plc, together with its subsidiaries, operates as a biotechnology company that y developing, and commercializing precision medicine tests for life-changing diseases in the United States and the United K…

Key Statistics

Company
Market Cap20.35M USD
Enterprise Value8.54M USD
Revenue (TTM)1.57M USD
Gross Profit687.39K USD
Net Income (TTM)-14.69M USD
Revenue/Share0.00 USD
Last Price0.0015 USD
Fiscal Year EndSep 2025
MR QuarterMar 2026
Employees37
CountryGB
SectorHealthcare
IndustryDiagnostics & Research
ISINGB00BD5H8572
Valuation
P/E (Trailing)—
P/E (Forward)-0.29
PEG—
EV/EBITDA-0.71
EV/Revenue5.43
P/S12.93
P/B1.15
EPS (TTM)0.00 USD
EPS (Forward)-0.0053 USD
52W Range
0.001113% of range0.0045
52W High0.0045 USD
52W Low0.0011 USD
Profitability
Gross Margin47.67%
Oper. Margin-799.33%
EBITDA Margin0.00%
Profit Margin-1018.54%
ROE-999.37%
ROA-137.93%
ROIC-217.04%
ROCE-196.11%
Growth
Revenue Growth17.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-9.97M USD
CapEx (TTM)321.31K USD
FCF Margin-327.47%
FCF Yield-25.32%
Net Debt2.33M USD
Net Debt/EBITDA-0.19
Net Debt/FCF—
Balance Sheet
Debt/Equity4.58
Current Ratio2.01
Quick Ratio1.89
Book Value/Sh0.0013 USD
Cash/Share0.0013 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)0.0040 USD
Upside (mean)+160.9%
Target Range0.0040 USD – 0.0040 USD
# Analysts1
Ownership
Shares Out.13.44B
Float3.27B
Insiders12.12%
Institutions39.17%
Technical
SMA 500.0015 (+3.8%)
SMA 2000.0022 (-29.7%)
Beta-0.19
S&P 52W Chg12.08%
Avg Vol (30d)66.30M
Avg Vol (10d)166.43M
Technical Indicators
RSI (14)55.8
MACD0.0006
MACD Signal-0.0006
MACD Hist.+0.0012
BB Upper0.0016 USD
BB Middle0.0014 USD
BB Lower0.0013 USD
BB Width24.99%
ATR (14)0.0003 USD
Vol Ratio (20d)0.72x

About Oxford BioDynamics (LON: OBD)

›

Oxford BioDynamics (LON: OBD) is listed on the London Stock Exchange, where its shares trade in pence sterling (GBp). It belongs to the Diagnostics & Research industry, part of the Healthcare sector, and reports about 37 employees.

The shares were at 0.1150 GBp on 19 November 2026, down 59.6% over 52 weeks. Its 52-week range is 0.0800 GBp to 0.3400 GBp: the price is 66.2% below the high and 43.8% above the low.

Its market capitalisation is 15.46M GBP.

Oxford BioDynamics reports revenue up 17.0% year over year.

Its debt exceeds its cash by 1.77M GBP, a debt-to-equity ratio of 4.58. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health. One analyst covers the stock, with an average rating of Strong Buy; their mean price target of 0.3000 GBp is 160.9% above the current price.